• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. INDIGO SYSTEM SEPARATOR 12; QEW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. INDIGO SYSTEM SEPARATOR 12; QEW Back to Search Results
Catalog Number SEP12
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hemoptysis (1887)
Date of Event 11/21/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.This report is associated with mfr report number: 3005168196-2023-00556.
 
Event or Problem Description
The patient was undergoing a thrombectomy procedure to treat a pulmonary embolism using an indigo system cat12 aspiration catheter (cat12), a lightning aspiration tubing (lightning), an indigo system separator 12 (sep12), and a penumbra engine (engine).During the procedure, the physician treated the left lung by removing the thrombus under aspiration using the cat12 and sep12.Shortly before the end of the procedure, the patient started coughing blood.The physician then noticed bleeding from a capillary in the left lung, indicating a vascular rupture.The patient was then ventilated, and it was reported that the bleeding stopped relatively quickly without any treatment.The procedure ended at this point.The patient''s current health status is good, with spontaneous breathing the day after the procedure.The relationship between hemoptysis, the cat12 and sep12 is unknown.
 
Additional Manufacturer Narrative
From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Hemoptysis is included as a possible complication in the instructions for use (ifu) for the indigo aspiration system.Evaluation of the returned sep12 revealed an undamaged device.There was no reported allegation against sep12.The sep12 was able to advance through the returned cat12 without an issue during evaluation.Penumbra devices are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This report is associated with mfr report number: 1.3005168196-2023-00556.
 
Event or Problem Description
The patient was undergoing a thrombectomy procedure to treat a pulmonary embolism using an indigo system cat12 aspiration catheter (cat12), a lightning aspiration tubing (lightning), an indigo system separator 12 (sep12), and a penumbra engine (engine).During the procedure, the physician treated the left lung by removing the thrombus under aspiration using the cat12 and sep12.Shortly before the end of the procedure, the patient started coughing blood.The physician then noticed bleeding from a capillary in the left lung.The patient was then ventilated, and it was reported that the bleeding stopped relatively quickly without any treatment.The procedure ended at this point.The patient's current health status is good, with spontaneous breathing the day after the procedure.The relationship between hemoptysis, the cat12 and sep12 is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INDIGO SYSTEM SEPARATOR 12
Common Device Name
QEW
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key18351252
Report Number3005168196-2023-00557
Device Sequence Number5341568
Product Code QEW
UDI-Device Identifier00815948021549
UDI-Public815948021549
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K202821
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/07/2024
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/20/2026
Device Catalogue NumberSEP12
Device Lot NumberH00002410
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/21/2023
Supplement Date Received by Manufacturer01/19/2024
Initial Report FDA Received Date12/18/2023
Supplement Report FDA Received Date02/07/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-